Amarin Corp Plcuk (AMRN) Other Non-Current Liabilities (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Other Non-Current Liabilities of $11.1 million for Q1 2026, down 4.47% YoY from $11.6 million in Q1 2025, and up 1.52% sequentially from $11.0 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Other Non-Current Liabilities across 17 years of filings, most recently posting $11.1 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 4.47% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $11.1 million (down 4.47% YoY), while the FY2025 annual figure was $11.0 million, down 4.75% from the prior year.
  • Other Non-Current Liabilities improved to $11.1 million in Q1 2026, from $11.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for AMRN reached as high as $12.0 million in Q3 2025 and fell as low as $7.2 million in Q2 2023.
  • The 5-year median for Other Non-Current Liabilities is $9.3 million (2024), against an average of $9.5 million.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 81.25% — and 2023, when it slipped 25.0%.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $8.2 million in 2022, then climbed by 10.47% to $9.1 million in 2023, then climbed by 26.89% to $11.5 million in 2024, then declined by 4.75% to $11.0 million in 2025, then grew by 1.52% to $11.1 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $11.1 million, $11.0 million, and $12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.12 Mn
Dec 31, 2025 10.96 Mn
Sep 30, 2025 11.96 Mn
Jun 30, 2025 11.92 Mn
Mar 31, 2025 11.64 Mn
Dec 31, 2024 11.50 Mn
Sep 30, 2024 9.47 Mn
Jun 30, 2024 9.34 Mn
Mar 31, 2024 9.20 Mn
Dec 31, 2023 9.06 Mn
Sep 30, 2023 7.27 Mn
Jun 30, 2023 7.16 Mn
Mar 31, 2023 8.61 Mn
Dec 31, 2022 8.21 Mn
Sep 30, 2022 9.70 Mn
Jun 30, 2022 7.64 Mn
Mar 31, 2022 7.49 Mn
Dec 31, 2021 7.65 Mn
Sep 30, 2021 5.35 Mn
Jun 30, 2021 5.53 Mn